☆ 4.6 Article

Automated Synthesis of [Ga-68]Ga-FAPI-46 on a Scintomics GRP Synthesizer

PHARMACEUTICALS (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Biochemistry & Molecular Biology

New Fully Automated Preparation of High Apparent Molar Activity 68Ga-FAPI-46 on a Trasis AiO Platform

Chiara Da Pieve et al.

Summary: A large number of applications for FAPI-based PET agents have been evaluated, including in cancer and non-malignant diseases. Ga-68-FAPI-46 showed high specificity and affinity for FAP-expressing cells, with fast accumulation in tumor lesions/injuries and quick body clearance. An automated synthesis for the production of Ga-68-FAPI-46 on a Trasis AiO platform was developed, resulting in high radiochemical purity and molar activity. The product's in vitro and in vivo properties were assessed on glioblastoma cells and mouse model.

MOLECULES (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Automated Synthesis of 68Ga-Labeled DOTA-MGS8 and Preclinical Characterization of Cholecystokinin-2 Receptor Targeting

Anton Amadeus Hoermann et al.

Summary: This study presents a new minigastrin analog, DOTA-MGS8, targeting the cholecystokinin-2 receptor (CCK2R). Ga-68-labeled DOTA-MGS8 was successfully synthesized using an automated synthesis module, and preclinical studies demonstrated its high receptor-specific cell internalization and favorable biodistribution profile. This suggests that stabilized MG analogs like DOTA-MGS8 have the potential for high-sensitivity positron emission tomography in patients with CCK2R-related malignancies.

MOLECULES (2022)

添加到收藏夹

Article Chemistry, Medicinal

Automated synthesis of [68Ga]Ga-FAPI-46 without pre-purification of the generator eluate on three common synthesis modules and two generator types

Ammar Alfteimi et al.

Summary: The study aimed to develop and evaluate a GMP-compliant automatic synthesis of [Ga-68]Ga-FAPI-46 using different Ge-68/Ga-68 generators and synthesis systems. Regardless of the generator or synthesis module used, the synthesis of [Ga-68]Ga-FAPI-46 could be completed in 12 minutes with over 99.5% chemical purity and a radiochemical yield of around 92.5% (decay corrected). All quality control parameters met the requirements of the European Pharmacopoeia.

EJNMMI RADIOPHARMACY AND CHEMISTRY (2022)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Safety of Fibroblast Activation Protein-Targeted Radionuclide Therapy by a Low-Dose Dosimetric Approach Using 177Lu-FAPI04

Serkan Kuyumcu et al.

Summary: This study aimed to estimate radiation-absorbed doses in normal organs and tumor tissue using low-dose Lu-177-FAPI04 dosimetry in metastatic cancer patients. Results showed low absorbed doses in risk organs, allowing for low tumor absorbed doses with higher administered doses. Further research on optimizing therapeutic efficacy and individualized dosimetric approach is needed.

CLINICAL NUCLEAR MEDICINE (2021)

添加到收藏夹

Review Oncology

Radioligands Targeting Fibroblast Activation Protein (FAP)

Thomas Lindner et al.

Summary: FAP-targeted radiotracers accumulate in Cancer-Associated Fibroblasts (CAFs) and can be utilized to discriminate between cancerous and healthy tissues. They show potential as pan-tumor agents and have better tumor-to-background ratios (TBR) compared to standard tumor tracers. The introduction of FAPI-tracers in 2018 sparked growing interest in nuclear medicine and radiopharmacy.

CANCERS (2021)

添加到收藏夹

Review Chemistry, Medicinal

New Frontiers in Cancer Imaging and Therapy Based on Radiolabeled Fibroblast Activation Protein Inhibitors: A Rational Review and Current Progress

Surachet Imlimthan et al.

Summary: The tumor microenvironment (TME) has become a new paradigm of cancer diagnosis and therapy in the past decade, with cancer-associated fibroblasts (CAFs) being identified as critical stromal cells that regulate tumor growth and progression. Research on FAP-based radiopharmaceuticals for visualizing malignancies and delivering theranostic radiopharmaceuticals to the TME has been intensively investigated. This review provides an overview of TME compositions, particularly CAFs and FAP, and their roles in cancer biology, as well as the challenges and requirements for radiolabeled FAP inhibitors in clinical translation.

PHARMACEUTICALS (2021)

添加到收藏夹

Article Chemistry, Medicinal

Guideline on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals

Nic Gillings et al.

Summary: This guideline for small-scale preparation of radiopharmaceuticals is based on the view of the Radiopharmacy Committee of EANM. It follows the format of EU GMP guidelines and is intended for non-commercial sites like hospital radiopharmacies, nuclear medicine departments, research PET centers, and healthcare establishments. The guideline aims to assist radiopharmacies in preparing safe diagnostic and therapeutic radiopharmaceuticals for human administration.

EJNMMI RADIOPHARMACY AND CHEMISTRY (2021)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

The Latest Developments in Imaging of Fibroblast Activation Protein

Annette Altmann et al.

Summary: Fibroblast activation protein (FAP) is highly expressed in cancer-associated fibroblasts and plays a role in cancer progression and prognosis. FAPI PET/CT imaging, as a promising approach for tumor diagnosis and treatment, offers advantages over conventional F-18-FDG PET/CT in terms of sensitivity and accuracy.

JOURNAL OF NUCLEAR MEDICINE (2021)

添加到收藏夹

Article Chemistry, Medicinal

Fully-automated production of [68Ga]Ga-FAPI-46 for clinical application

Sarah Spreckelmeyer et al.

EJNMMI RADIOPHARMACY AND CHEMISTRY (2020)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Development of Fibroblast Activation Protein-Targeted Radiotracers with Improved Tumor Retention

Anastasia Loktev et al.

JOURNAL OF NUCLEAR MEDICINE (2019)

添加到收藏夹

Review Chemistry, Medicinal

Targeting of activated fibroblasts for imaging and therapy

Thomas Lindner et al.

EJNMMI RADIOPHARMACY AND CHEMISTRY (2019)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein

Thomas Lindner et al.

JOURNAL OF NUCLEAR MEDICINE (2018)

添加到收藏夹

Article Oncology

Fibroblast activation protein-alpha, a stromal cell surface protease, shapes key features of cancer associated fibroblasts through proteome and degradome alterations

M. M. Koczorowska et al.

MOLECULAR ONCOLOGY (2016)

添加到收藏夹

Review Cell Biology

Carcinoma-associated fibroblasts: orchestrating the composition of malignancy

Philippe Gascard et al.

GENES & DEVELOPMENT (2016)

添加到收藏夹

Review Oncology

Fibroblast activation protein α in tumor microenvironment: Recent progression and implications

Fuming Zi et al.

MOLECULAR MEDICINE REPORTS (2015)

添加到收藏夹

Article Biochemistry & Molecular Biology

Evaluation of the Radiolabeled Boronic Acid-Based FAP Inhibitor MIP-1232 for Atherosclerotic Plaque Imaging

Romana Meletta et al.

MOLECULES (2015)

添加到收藏夹

Review Biochemical Research Methods

Understanding fibroblast activation protein (FAP): Substrates, activities, expression and targeting for cancer therapy

Elizabeth J. Hamson et al.

PROTEOMICS CLINICAL APPLICATIONS (2014)

添加到收藏夹

Article Chemistry, Medicinal

Selective Inhibitors of Fibroblast Activation Protein (FAP) with a (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine Scaffold

Koen Jansen et al.

ACS MEDICINAL CHEMISTRY LETTERS (2013)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.